Intelligence Platform
Patents
Browse 1,756 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 9290541
TCL1 peptides for immunotherapy
granted patentUS 9289408
High concentration baclofen preparations
granted patentUS 9289131
Method and apparatus to identify vulnerable plaques with thermal wave imaging of heated na
granted patentUS 9283185
Liposomal curcumin for treatment of cancer
granted patentUS 9278923
Pro-neurogenic compounds
granted patentUS 9278113
Titanium dioxide nanotubes for production and delivery of nitric oxide and methods for pro
granted patentUS 9278068
Vesicle compositions
granted patentUS 9273288
Pseudoinfectious flavivirus and uses thereof
granted patentUS 9272991
Eicosanoid derivatives
granted patentUS 9265844
Protease degradable polypeptides and uses thereof
granted patentUS 9267947
Compositions and methods for preventing or treating Burkholderia infection
granted patentUS 9260510
Pertussis antibodies and uses thereof
granted patentUS 9248147
Methods for endoscopic mucosal resection and endoscopic submucosal dissection
granted patentUS 9250239
Compositions and methods for detecting microbial infections
granted patentUS 9243055
HERV-K antigens, antibodies, and methods
granted patentUS 9241999
Method of producing physiological and therapeutic levels of nitric oxide through an oral d
granted patentUS 9241998
Methods and compositions for treatment of cancer using oncolytic RSV activity
granted patentUS 9243351
Fabrication of biscrolled fiber using carbon nanotube sheet
granted patentUS 9243281
Neuroprotective chemicals and methods for identifying and using same
granted patentUS 9238653
Antimalarial agents that are inhibitors of dihydroorotate dehydrogenase
granted patentUS 9233162
High affinity VEGF-receptor antagonists
granted patentUS 9221800
Isoxazole treatments for diabetes
granted patentUS 9216220
Compositions and methods for thermo-sensitive nanoparticles and magnetic nanoparticles
granted patentUS 9216983
Dihydroorotate dehydrogenase inhibitors with selective anti-malarial activity
granted